Health AI Central
Share:
Peer-Reviewed Publication
Lancet Haematol2020;7(6):e432-e435.June 1, 2020Journal Article

Effect of the COVID-19 pandemic on cancer treatment and research.

Kamal S Saini1, Begoña de Las Heras2, Javier de Castro3, Ramachandran Venkitaraman4, Martine Poelman5, Gopalakrishnan Srinivasan4, Monika Lamba Saini6, Sanjeev Verma7, Manuela Leone5, Philippe Aftimos8, Giuseppe Curigliano9
1Covance Inc, Princeton, NJ, USA; East Suffolk and North Essex National Health Service Foundation Trust, Ipswich, UK.
2Covance Inc, Princeton, NJ, USA; Madrid Medical Doctors Association, Madrid, Spain.
3Madrid Medical Doctors Association, Madrid, Spain; La Paz Hospital, Madrid, Spain.
4East Suffolk and North Essex National Health Service Foundation Trust, Ipswich, UK.
5Covance Inc, Princeton, NJ, USA.
6HistoGeneX, Antwerp, Belgium.
7Quantum Health Analytics, Wezembeek-Oppem, Belgium.
8Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
9Istituto Europeo di Oncologia, IRCCS, Milan, Italy; University of Milano, Milan, 20141, Italy. Electronic address: giuseppe.curigliano@ieo.it.
PubMed PMC DOI PDF

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.